1. CCR5 in T Cell-Mediated Liver Diseases: What’s Going On?
2. Baxter A, Johnson T, Kindon N, Roberts B, Steele J, Stocks M, and Tomkinson N (2003a), inventors; AstraZeneca AB, Baxter A, Johnson T, Kindon N, et al., assignees. Preparation of N-pyrazinylthiophenesulfonamides as chemokine receptor modulators. World patent WO2003051870. 2003 June 26.
3. Baxter A, Johnson T, Kindon N, Roberts B, and Stocks M (2003b), inventors; AstraZeneca AB, Baxter A, Johnson T, Kindon N, et al., assignees. Preparation of N-pyrazinylbenzenesulfonamides as their use in the treatment of chemokine mediated diseases such as asthma. World patent WO2003059893. 2003 July 24.
4. Baxter A, Kindon N, and Stocks M (2005), inventors
5. AstraZeneca AB, Baxter A, Kindon N, and Stocks M, assignees. Preparation of condensed N-pyrazinyl-sulfonamides as their use in the treatment of chemokine mediated diseases. World patent WO2005021513. 2005 March 10.